AbbVie (ABBV) News Today $182.95 +1.15 (+0.63%) As of 03:21 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Why is AbbVie Up Today?AbbVie Inc. (NYSE: ABBV) shares have dipped amid a mix of legal rulings, analyst rating adjustments and broader market moves, even as the company’s underlying business model and dividend profile receive positive reinforcement. Renaissance Investment Management highlighted AbbVie’s stable and highly profitable business model in its Q1 “Large Cap Growth Strategy” letter. An Illinois court upheld the dismissal of the AbbVie-Allergan merger lawsuit, removing a key legal overhang. The Motley Fool included AbbVie in its list of “2 Incredible Dividend Growth Stocks to Buy Now,” underscoring its attractive income potential. Shares have traded modestly lower, with recent intraday declines of approximately 0.5% and 1%, reflecting overall market volatility. StockNews.com downgraded AbbVie from a “strong-buy” to a “buy,” signalling a slightly less bullish analyst stance. A series of class-action notices tied to Cerevel Therapeutics (misattributed to ABBV) have circulated, creating legal noise and investor uncertainty. Competitor Genentech’s renewed investment in molecular glue therapies (Orionis) highlights intensifying competition in AbbVie’s R&D space. Investors should balance these near-term headwinds against AbbVie’s robust cash flow, dividend track record and favorable long-term outlook.Posted 1h agoAI generated ABBV Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period AbbVie (NYSE:ABBV) Trading Down 0.5% - Here's What HappenedAbbVie (NYSE:ABBV) Trading Down 0.5% - Here's WhyMay 22 at 2:19 PM | marketbeat.comLevi & Korsinsky Notifies Shareholders of Cerevel Therapeutics Holdings, Inc. (ABBV) of a Class Action Lawsuit and an Upcoming DeadlineMay 22 at 1:47 PM | globenewswire.comAbbVie (ABBV) has a Stable and Highly Profitable Business ModelMay 22 at 9:57 AM | insidermonkey.comNovem Group Takes Position in AbbVie Inc. (NYSE:ABBV)Novem Group purchased a new stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 6,580 shares of the company's stock, valued at approximately $1,169,000. Several other institutional iMay 22 at 8:01 AM | marketbeat.comBRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Grows Stock Holdings in AbbVie Inc. (NYSE:ABBV)BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp lifted its position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 14.8% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 338,238 shares of the company's stock after buyinMay 22 at 7:50 AM | marketbeat.comFocus Partners Advisor Solutions LLC Raises Stock Holdings in AbbVie Inc. (NYSE:ABBV)Focus Partners Advisor Solutions LLC raised its position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 10.2% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 37,396 shares of the company's stock after purMay 22 at 7:41 AM | marketbeat.comAmes National Corp Invests $260,000 in AbbVie Inc. (NYSE:ABBV)Ames National Corp acquired a new stake in AbbVie Inc. (NYSE:ABBV - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 1,465 shares of the company's stock, valued at approximatMay 22 at 7:16 AM | marketbeat.comCerevel Therapeutics Holdings, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before June 3, 2025 to Discuss Your Rights - ABBVMay 22 at 5:45 AM | prnewswire.comTeza Capital Management LLC Has $250,000 Position in AbbVie Inc. (NYSE:ABBV)Teza Capital Management LLC lessened its stake in AbbVie Inc. (NYSE:ABBV - Free Report) by 72.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,407 shares of the company's stock after selling 3,629 shares during the peMay 22 at 5:36 AM | marketbeat.comAbbVie (NYSE:ABBV) Stock Price Down 1% - Here's WhyAbbVie (NYSE:ABBV) Shares Down 1% - What's Next?May 21 at 3:09 PM | marketbeat.comCerevel Therapeutics Holdings, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before June 3, 2025 to Discuss Your Rights – ABBVMay 21 at 1:20 PM | globenewswire.comPrincipal Street Partners LLC Trims Position in AbbVie Inc. (NYSE:ABBV)Principal Street Partners LLC cut its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 10.8% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 37,013 shares of the company's stock after selling 4,479 shares during the period. AbbVie comprises aboMay 21 at 7:59 AM | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $2.14 Billion Stake in AbbVie Inc. (NYSE:ABBV)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 18.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 12,058,706 shares of the company'May 21 at 7:18 AM | marketbeat.comAbbVie Inc. (NYSE:ABBV) Position Cut by USS Investment Management LtdUSS Investment Management Ltd trimmed its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 2.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 470,730 shares of the company's stock after selling 13,433 shares during the period. USSMay 21 at 7:06 AM | marketbeat.com2 Incredible Dividend Growth Stocks to Buy NowMay 21 at 6:55 AM | fool.comWorldquant Millennium Advisors LLC Reduces Stock Position in AbbVie Inc. (NYSE:ABBV)Worldquant Millennium Advisors LLC reduced its position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 28.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 416,351 shares of the company's stock after sMay 21 at 6:52 AM | marketbeat.comAbbVie Inc. (NYSE:ABBV) Stock Holdings Increased by Waverly Advisors LLCWaverly Advisors LLC boosted its position in AbbVie Inc. (NYSE:ABBV - Free Report) by 15.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 114,340 shares of the company's stock after buying an additionalMay 21 at 6:43 AM | marketbeat.comWellington Wealth Strategies LLC. Sells 2,475 Shares of AbbVie Inc. (NYSE:ABBV)Wellington Wealth Strategies LLC. trimmed its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 56.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,882 shares of the company'May 21 at 6:43 AM | marketbeat.comAbbVie Inc. (NYSE:ABBV) Shares Sold by Woodline Partners LPWoodline Partners LP lowered its stake in AbbVie Inc. (NYSE:ABBV - Free Report) by 25.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 605,058 shares of the company's stock after selling 203,678 shares during theMay 21 at 6:09 AM | marketbeat.comZurich Insurance Group Ltd FI Buys 43,991 Shares of AbbVie Inc. (NYSE:ABBV)Zurich Insurance Group Ltd FI grew its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 11.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 420,327 shares of the company's stock afterMay 21 at 6:07 AM | marketbeat.comSiemens Fonds Invest GmbH Boosts Holdings in AbbVie Inc. (NYSE:ABBV)Siemens Fonds Invest GmbH lifted its position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 197.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 179,440 shares of the company's stock after purchasing an aMay 21 at 5:05 AM | marketbeat.comAbbVie (NYSE:ABBV) Stock Price Up 0.2% - Here's WhyAbbVie (NYSE:ABBV) Trading Up 0.2% - Time to Buy?May 20 at 4:42 PM | marketbeat.com69 May Aristocrats: Buy 1 Of 38 "Safer" Dividend DogsMay 20 at 4:16 PM | seekingalpha.comAbbVie (ABBV) Soared on Favorable TailwindsMay 20 at 10:25 AM | finance.yahoo.comAbbVie (ABBV) Soared on Favorable TailwindsMay 20 at 10:13 AM | insidermonkey.comVictrix Investment Advisors Invests $1.02 Million in AbbVie Inc. (NYSE:ABBV)Victrix Investment Advisors bought a new position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 5,761 shares of the company's stock, valued at approxMay 20 at 8:14 AM | marketbeat.comVident Advisory LLC Acquires 15,110 Shares of AbbVie Inc. (NYSE:ABBV)Vident Advisory LLC increased its position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 19.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 92,617 shares of the company's stock after acquiring an additional 15,110May 20 at 7:57 AM | marketbeat.comTriglav Skladi D.O.O. Invests $6.70 Million in AbbVie Inc. (NYSE:ABBV)Triglav Skladi D.O.O. acquired a new position in AbbVie Inc. (NYSE:ABBV - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm acquired 37,721 shares of the company's stock, valued at approximately $6,703,000. A number of other large investors have alsoMay 20 at 6:55 AM | marketbeat.comShareholders that lost money on Cerevel Therapeutics Holdings, Inc.(ABBV) should contact Levi & Korsinsky about pending Class Action - ABBVMay 20 at 5:45 AM | prnewswire.comAbbVie Inc. (NYSE:ABBV) Receives $210.95 Consensus PT from BrokeragesMay 20 at 3:09 AM | americanbankingnews.comShareholders that lost money on Cerevel Therapeutics Holdings, Inc. ...May 19 at 2:30 PM | gurufocus.comTop Biotech Stocks To Watch Today - May 18thAbbVie, Thermo Fisher Scientific, Danaher, Vertex Pharmaceuticals, Cognizant Technology Solutions, Veeva Systems, and Cencora are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of publicly traded companies that research, develop andMay 19 at 2:02 PM | marketbeat.comLevi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Cerevel Therapeutics Holdings, Inc. (ABBV) ShareholdersMay 19 at 1:30 PM | globenewswire.comShareholders that lost money on Cerevel Therapeutics Holdings, Inc.(ABBV) should contact The Gross Law Firm about pending Class Action - ABBVMay 19 at 1:04 PM | prnewswire.comThe Only 5 ETFs You Need to Build Wealth for RetirementMay 19 at 8:57 AM | 247wallst.comTemasek Holdings Private Ltd Lowers Stock Position in AbbVie Inc. (NYSE:ABBV)Temasek Holdings Private Ltd trimmed its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 81.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 42,473 shares of the company's stockMay 19 at 7:50 AM | marketbeat.comTexas Bank & Trust Co Makes New Investment in AbbVie Inc. (NYSE:ABBV)Texas Bank & Trust Co acquired a new stake in AbbVie Inc. (NYSE:ABBV - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 6,342 shares of the company's stock, valued at approximately $1,127,000. Several other insMay 19 at 7:41 AM | marketbeat.com1,620 Shares in AbbVie Inc. (NYSE:ABBV) Acquired by Trace Wealth Advisors LLCTrace Wealth Advisors LLC bought a new position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund bought 1,620 shares of the company's stock, valued at approximately $288,000. A number of other institutiMay 19 at 7:39 AM | marketbeat.comState of Wyoming Buys 6,612 Shares of AbbVie Inc. (NYSE:ABBV)State of Wyoming boosted its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 66,120.0% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 6,622 shares of the company's stock after acquiring an additMay 19 at 7:04 AM | marketbeat.comStrategic Global Advisors LLC Raises Stock Holdings in AbbVie Inc. (NYSE:ABBV)Strategic Global Advisors LLC lifted its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 18.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 24,372 shares of the company's stock after buyinMay 19 at 6:46 AM | marketbeat.comStrategic Wealth Partners Ltd. Buys 4,343 Shares of AbbVie Inc. (NYSE:ABBV)Strategic Wealth Partners Ltd. raised its stake in AbbVie Inc. (NYSE:ABBV - Free Report) by 11.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 41,550 shares of the company's stock after acquiring an addiMay 19 at 6:46 AM | marketbeat.comPromising Biotech Stocks To Follow Today - May 17thAbbVie, Thermo Fisher Scientific, Danaher, Vertex Pharmaceuticals, Cognizant Technology Solutions, Veeva Systems, and Cencora are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of publicly traded companies that focus on the researchMay 18, 2025 | marketbeat.comDon't Fall for These 3 Dividend Stocks: They May Have to Make a Cut.May 18, 2025 | fool.comAbbVie Inc. (NYSE:ABBV) Shares Acquired by Toronto Dominion BankToronto Dominion Bank increased its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 10.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 770,392 shares of the company's stock after acquiring an additional 72,515May 18, 2025 | marketbeat.comSilvercrest Asset Management Group LLC Sells 22,241 Shares of AbbVie Inc. (NYSE:ABBV)Silvercrest Asset Management Group LLC cut its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 15.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 125,712 shares of the company's stock after selling 22,24May 18, 2025 | marketbeat.comJim Cramer On AbbVie: Makes “Sense To Start a Position in the Stock”May 17, 2025 | finance.yahoo.comAbbVie (NYSE:ABBV) Trading Up 0.3% - Should You Buy?AbbVie (NYSE:ABBV) Stock Price Up 0.3% - Here's WhyMay 17, 2025 | marketbeat.comRep. Josh Gottheimer Buys AbbVie Inc. (NYSE:ABBV) StockRepresentative Josh Gottheimer (D-New Jersey) recently bought shares of AbbVie Inc. (NYSE:ABBV). In a filing disclosed on May 14th, the Representative disclosed that they had bought between $1,001 and $15,000 in AbbVie stock on April 1st. The trade occurred in the Representative's "MORGAN STANLEY -May 17, 2025 | marketbeat.comBiotech Stocks To Follow Today - May 16thAbbVie, Thermo Fisher Scientific, Danaher, SpringWorks Therapeutics, Vertex Pharmaceuticals, Moderna, and GSK are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of companies that research, develop and commercialize products using biMay 17, 2025 | marketbeat.comAbbVie (NYSE:ABBV) Stock Acquired Rep. Josh GottheimerRepresentative Josh Gottheimer (D-New Jersey) recently bought shares of AbbVie Inc. (NYSE:ABBV). In a filing disclosed on May 14th, the Representative disclosed that they had bought between $1,001 and $15,000 in AbbVie stock on April 3rd. The trade occurred in the Representative's "MORGAN STANLEY -May 17, 2025 | marketbeat.com Get AbbVie News Delivered to You Automatically Sign up to receive the latest news and ratings for ABBV and its competitors with MarketBeat's FREE daily newsletter. Email Address ABBV Media Mentions By Week ABBV Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ABBV News Sentiment▼0.860.65▲Average Medical News Sentiment ABBV News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ABBV Articles This Week▼7554▲ABBV Articles Average Week Get AbbVie News Delivered to You Automatically Sign up to receive the latest news and ratings for ABBV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies LLY News Today JNJ News Today MRK News Today PFE News Today BMY News Today ZTS News Today RPRX News Today CORT News Today JAZZ News Today PRGO News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:ABBV) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AbbVie Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AbbVie With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ABBV Stock Free ABBV Stock Alerts